The potential importance of the HMGB1-RAGE interaction in promoting tumour progression is supported by a recent report showing that RAGE and HMGB1 are associated with the progression of prostate cancer and poor patient outcome57. The gene discussed is AGER; the disease is prostate carcinoma.